January/February 2024

January/February 2024 - PharmaTimes

Published on 23 January 2024

Description:

We peruse the priorities for 2024 – innovation, partnerships and a focus on unmet clinical needs. Meanwhile, we focus on the healthcare horoscope of politics, tech, data, public health and the rise of the patient. Hop on for the ride as we ask how the NHS will be reconstructed, if the success in hepatitis C elimination can be repeated in HIV, why gene therapy challenges must be embraced and if we can realise the potential of real-world data throughout industry.

Categories:

PharmaTimes

Preview:

25 articles from this collection:

Cover

2 - Pharmatimes USCROY

3 - From the editor

This month PharmaTimes presents Alantra’s annual ranking of the fastest growing pharma companies in the UK, and again there is much cause for celebration.

4-5 - Contents

6 - NEWS: Treatments

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched a public consultation on the potential reclassification of two progestogen-only, oral contraceptive pills containing desogestrel: Lovima 75mcg and Hana 75mcg film-coated tablets.

7 - NEWS: Research

8 - NEWS: COLLABORATION

9 - NEWS: Conditions

10-12 - 2024: Epic trail!

13 - Advertisements

14-15 - HIV/HEPATITIS C: Collaborating for change

16-17 - CLINICAL TRIALS - Happy anniversary!?

18-19 - GENE THERAPY: Outline of the future

20-21 - DATA: Healthcare flare

22-23 - CANCER: Sphere of influence

24-25 - MEDICINE: Purpose puzzle

26-27 - CRYSTAL BALL: Years and years

28-29 - FUTURE: Big reset!

30-31 - NEUROLOGY - Meeting of minds

32-33 - LIVER: Hard to process

34-35 - DIABETES - Foot hold

36-37 - Your moves

38 - AI – Major rethink

39 - Samedan

40 - Communique 2024

PharmaTimes

PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.

PharmaTimes print and digital magazine has a distributed circulation of 19,000, reaching right across the industry into every company and every function, bridging the gap between Pharma and the NHS.

editorial@pharmatimes.com

https://pharmatimes.com/